Bank of America
CDAK

Bank of America’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Bank of America’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-53,055
Closed -$9.23K – 8204
2023
Q1 		$9.23K Buy
53,055
+4,483
+9% +$2.5K ﹤0.01% 6933
2022
Q4 		$19.3K Buy
48,572
+34,016
+234% +$22.4K ﹤0.01% 6750
2022
Q3 		$11K Buy
14,556
+14,408
+9,735% +$30.2K ﹤0.01% 7220
2022
Q2 		$0 Sell
148
-49,495
-100% -$174K ﹤0.01% 8662
2022
Q1 		$311K Buy
49,643
+41,009
+475% +$257K ﹤0.01% 6161
2021
Q4 		$96K Buy
8,634
+1,517
+21% +$21K ﹤0.01% 6905
2021
Q3 		$117K Buy
7,117
+2,855
+67% +$51.1K ﹤0.01% 6636
2021
Q2 		$79K Sell
4,262
-4,117
-49% -$79.1K ﹤0.01% 6631
2021
Q1 		$126K Sell
8,379
-4,303
-34% -$93.6K ﹤0.01% 6294
2020
Q4 		$409K Buy
+12,682
New +$168K ﹤0.01% 5140

Bank of America's CDAK Position: Q2 2023 in Review

Bank of America sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 53,055 shares — an estimated $9.23K sold.

Bank of America first reported a position in CDAK in Q4 2020 and held it in 10 quarters. The position peaked at $409K in Q4 2020. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

  • Bank of America reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bank of America sold 53,055 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $9.23K.
  • Bank of America first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Bank of America's Codiak BioSciences, Inc. Common Stock position peaked at $409K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.